Document Detail


Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection.
MedLine Citation:
PMID:  9011628     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Preconditioned hearts release less purines during ischemia than virgin hearts. This study tested whether this reduced purine production is related to the mechanism of protection by ischemic preconditioning. Coronary effluent from isolated rabbit hearts was collected and purine (adenosine + inosine + hypoxanthine) levels were measured. All hearts underwent two cycles of 5 min global ischemia, each followed by 10 min reperfusion. In the first minute of reflow after the first ischemic period untreated hearts released 155 +/- 14 nmol purines per g wet weight, but only 104 +/- 16 nmol/g following the second bout of ischemia (P < 0.05). Thus, preconditioned hearts released less purines during ischemia. When 8-(p-sulfophenyl)theophylline (100 microM), which prevents the infarct size-limiting effect of ischemic preconditioning by blocking adenosine receptors was present in the perfusate, the pattern of purine release was not altered (151 +/- 13 nmol/g during the first minute after the first 5-min ischemic episode dropping to 117 +/- 6 nmol/g after the second ischemic period P < 0.05). Furthermore, pharmacological preconditioning with 5 min exposure of the heart to either adenosine (10 microM) or phenylephrine (0.1 microM) 15 min prior to the first ischemia did not affect purine release during early reperfusion after either the first (144 +/- 16 nmol/g and 153 +/- 12 nmol/g, respectively) or second (84 +/- 12 nmol/g and 111 +/- 9 nmol/g, respectively) bout of ischemia. Since the attenuated purine release was apparently unaffected by the presence or absence of a protected state, we conclude that this pattern is unrelated to the mechanism by which preconditioning protects the heart.
Authors:
M Goto; M V Cohen; D G van Wylen; J M Downey
Related Documents :
16098598 - Drug-induced delayed cardiac protection against the effects of myocardial ischemia.
11011038 - Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolate...
19816998 - Cardioprotective effects of anesthetic preconditioning in rats with ischemia-reperfusio...
10844838 - Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kin...
17719288 - Impact of ramipril on the incidence of atrial fibrillation: results of the heart outcom...
11163738 - Early neurohormonal effects of trandolapril in patients with left ventricular dysfuncti...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of molecular and cellular cardiology     Volume:  28     ISSN:  0022-2828     ISO Abbreviation:  J. Mol. Cell. Cardiol.     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1997-02-05     Completed Date:  1997-02-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0262322     Medline TA:  J Mol Cell Cardiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  447-54     Citation Subset:  IM    
Affiliation:
Department of Physiology, University of South Alabama, College of Medicine, Mobile 36688, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / metabolism,  pharmacology
Animals
Female
Heart / drug effects
Hemodynamics
Hypoxanthines / metabolism
Inosine / metabolism
Ischemic Preconditioning, Myocardial*
Male
Myocardial Ischemia / metabolism*
Myocardium / metabolism*
Phenylephrine / pharmacology
Purines / biosynthesis*
Rabbits
Receptors, Purinergic P1 / antagonists & inhibitors,  metabolism
Theophylline / analogs & derivatives,  pharmacology
Grant Support
ID/Acronym/Agency:
HL-20648/HL/NHLBI NIH HHS; HL-50688/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Hypoxanthines; 0/Purines; 0/Receptors, Purinergic P1; 120-73-0/purine; 58-55-9/Theophylline; 58-61-7/Adenosine; 58-63-9/Inosine; 59-42-7/Phenylephrine; 80206-91-3/8-(4-sulfophenyl)theophylline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cross-talk between ATP-regulated K+ channels and Na+ transport via cellular metabolism in frog skin ...
Next Document:  The presence and partitioning of calcium binding proteins in hepatic and cardiac nuclei.